The association of chronic liver disorders with exacerbation of symptoms and complications related to COVID-19: A systematic review and meta-analysis of cohort studies.
Clin Respir J
; 16(12): 777-792, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2078415
ABSTRACT
INTRODUCTION:
The aim of this review was to combine the results of published cohort studies to determine the exact association between chronic liver disorders, and the severe form of COVID-19, and its associated complications.METHODS:
This meta-analysis employed a keyword search (COVID-19 and chronic liver disorders) using PubMed (Medline), Scopus, Web of Sciences, and Embase (Elsevier). All articles related from January 2019 to May 2022 were reviewed. The STATA software was used for analysis.RESULTS:
The risk of death in COVID-19 patients with chronic liver disorders was higher than in ones without the chronic liver disease (RR 1.52; CI 95% 1.46-1.57; I2 86.14%). Also, the risk of acute respiratory distress syndrome (ARDS) and hospitalization in COVID-19 patients with chronic liver disorders was higher than in ones without the chronic liver disease ([RR 1.65; CI 95% 1.09-2.50; I2 0.00%] and [RR 1.39; CI 95% 1.23-1.58; I2 0.20%]). Also, the meta-analysis showed cough, headache, myalgia, nausea, diarrhea, and fatigue were 1.37 (CI 95% 1.20-1.55), 1.23 (CI 95% 1.09-1.38), 1.25 (CI 95% 1.04-1.50), 1.19 (CI 95% 1.02-1.40), 1.89 (CI 95% 1.30-2.75), 1.49 (CI 95% 1.07-2.09), and 1.14 (CI 95% 0.98-1.33), respectively, whereas the risk of all these symptoms was higher in COVID-19 patients with chronic liver diseases than ones without chronic liver disorders.CONCLUSION:
The mortality and complications due to COVID-19 were significantly different between patients with the chronic liver disease and the general population.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
COVID-19
/
Hepatopatías
Tipo de estudio:
Estudio de cohorte
/
Estudio observacional
/
Estudio pronóstico
/
Revisiones
/
Revisión sistemática/Meta análisis
Tópicos:
Covid persistente
Límite:
Humanos
Idioma:
Inglés
Revista:
Clin Respir J
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Crj.13552
Similares
MEDLINE
...
LILACS
LIS